InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Marshall Keith W. Director active across 1 company, notably Prometheus Biosciences, Inc.. In total, 7 disclosures have been recorded. History available since 9 December 2022. The latest transaction was filed on 2 June 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Marshall Keith W is an insider linked to Prometheus Biosciences, Inc., where he is Chief Financial Officer. The record shows 7 filings in total, and across the sampled recent filings from 2022-12-13 to 2023-06-16, the modal transaction nature is option exercise.